Patents by Inventor Dmitry Malin

Dmitry Malin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION CANCER TREATMENT
    Publication number: 20170049725
    Abstract: Described herein is TRAIL receptor targeting therapy in combination with metformin for treatment of cancer in humans. Using TRAIL receptor targeting therapy such as the TRAIL molecule, agonistic human monoclonal antibodies against TRAIL receptors, or peptides targeting TRAIL receptors in combination with metformin for the treatment of all types of cancer allows to obtain an optimum therapeutical effect at any time of the progression of the disease.
    Type: Application
    Filed: May 7, 2015
    Publication date: February 23, 2017
    Inventors: Vincent Leonard Cryns, Dmitry Malin, Elena Strekalova
  • COMBINATION CANCER TREATMENT
    Publication number: 20160310451
    Abstract: Described herein is TRAIL receptor targeting therapy in combination with metformin for treatment of cancer in humans. Using TRAIL receptor targeting therapy such as the TRAIL molecule, agonistic human monoclonal antibodies against TRAIL receptors, or peptides targeting TRAIL receptors in combination with metformin for the treatment of all types of cancer allows to obtain an optimum therapeutical effect at any time of the progression of the disease.
    Type: Application
    Filed: May 7, 2015
    Publication date: October 27, 2016
    Inventors: Vincent Leonard Cryns, Dmitry Malin, Elena Strekalova
  • COMBINATION CANCER TREATMENT
    Publication number: 20160101071
    Abstract: Described herein is TRAIL receptor targeting therapy in combination with metformin for treatment of cancer in humans. Using TRAIL receptor targeting therapy such as the TRAIL molecule, agonistic human monoclonal antibodies against TRAIL receptors, or peptides targeting TRAIL receptors in combination with metformin for the treatment of all types of cancer allows to obtain an optimum therapeutical effect at any time of the progression of the disease.
    Type: Application
    Filed: April 21, 2015
    Publication date: April 14, 2016
    Inventors: Vincent Leonard Cryns, Dmitry Malin, Elena Strekalova